163 related articles for article (PubMed ID: 34156255)
1. Claudin14 promotes colorectal cancer progression via the PI3K/AKT/mTOR pathway.
Qiao TY; Yuan ZM; Ma TY; Hu HQ; Zhu YH; Zhang WY; Zhang Q; Huang R; Tang QC; Wang GY; Wang XS
Neoplasma; 2021 Sep; 68(5):947-954. PubMed ID: 34156255
[TBL] [Abstract][Full Text] [Related]
2. Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway.
Yin F; Huang X; Xuan Y
Dis Markers; 2021; 2021():9950663. PubMed ID: 34512817
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppressive effect of scavenger receptor class A member 5 overexpression in colorectal cancer by regulating PI3K/AKT/mTOR pathway.
Li Y; Peng F; Tan X; Wang J; Xu Y
Genes Genomics; 2021 Oct; 43(10):1189-1198. PubMed ID: 34417976
[TBL] [Abstract][Full Text] [Related]
4. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
5. Effects of Glut1 gene silencing on proliferation, differentiation, and apoptosis of colorectal cancer cells by targeting the TGF-β/PI3K-AKT-mTOR signaling pathway.
Wu XL; Wang LK; Yang DD; Qu M; Yang YJ; Guo F; Han L; Xue J
J Cell Biochem; 2018 Feb; 119(2):2356-2367. PubMed ID: 28884839
[TBL] [Abstract][Full Text] [Related]
6. HOTAIR/miR-326/FUT6 axis facilitates colorectal cancer progression through regulating fucosylation of CD44 via PI3K/AKT/mTOR pathway.
Pan S; Liu Y; Liu Q; Xiao Y; Liu B; Ren X; Qi X; Zhou H; Zeng C; Jia L
Biochim Biophys Acta Mol Cell Res; 2019 May; 1866(5):750-760. PubMed ID: 30742932
[TBL] [Abstract][Full Text] [Related]
7. High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors.
Smit DJ; Cayrefourcq L; Haider MT; Hinz N; Pantel K; Alix-Panabières C; Jücker M
Cells; 2020 Sep; 9(9):. PubMed ID: 32962206
[TBL] [Abstract][Full Text] [Related]
8. The PI3K/Akt/mTOR axis in colorectal cancer: Oncogenic alterations, non-coding RNAs, therapeutic opportunities, and the emerging role of nanoparticles.
Sanaei MJ; Baghery Saghchy Khorasani A; Pourbagheri-Sigaroodi A; Shahrokh S; Zali MR; Bashash D
J Cell Physiol; 2022 Mar; 237(3):1720-1752. PubMed ID: 34897682
[TBL] [Abstract][Full Text] [Related]
9. MUC3A promotes the progression of colorectal cancer through the PI3K/Akt/mTOR pathway.
Su W; Feng B; Hu L; Guo X; Yu M
BMC Cancer; 2022 Jun; 22(1):602. PubMed ID: 35655161
[TBL] [Abstract][Full Text] [Related]
10. Silencing of FOXO6 inhibits the proliferation, invasion, and glycolysis in colorectal cancer cells.
Li Q; Tang H; Hu F; Qin C
J Cell Biochem; 2019 Mar; 120(3):3853-3860. PubMed ID: 30321450
[TBL] [Abstract][Full Text] [Related]
11. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
[TBL] [Abstract][Full Text] [Related]
12. P300 increases CSNK2A1 expression which accelerates colorectal cancer progression through activation of the PI3K-AKT-mTOR axis.
Liu J
Exp Cell Res; 2023 Sep; 430(1):113694. PubMed ID: 37391010
[TBL] [Abstract][Full Text] [Related]
13. RFC2 promotes aerobic glycolysis and progression of colorectal cancer.
Lou F; Zhang M
BMC Gastroenterol; 2023 Oct; 23(1):353. PubMed ID: 37821801
[TBL] [Abstract][Full Text] [Related]
14. Activation of the PI3K/Akt/mTOR/p70S6K pathway is involved in S100A4-induced viability and migration in colorectal cancer cells.
Wang H; Duan L; Zou Z; Li H; Yuan S; Chen X; Zhang Y; Li X; Sun H; Zha H; Zhang Y; Zhou L
Int J Med Sci; 2014; 11(8):841-9. PubMed ID: 24936148
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression.
Li Y; Zeng C; Hu J; Pan Y; Shan Y; Liu B; Jia L
J Hematol Oncol; 2018 Jul; 11(1):89. PubMed ID: 29970122
[TBL] [Abstract][Full Text] [Related]
16. Cross-talk between non-coding RNAs and PI3K/AKT/mTOR pathway in colorectal cancer.
Moafian Z; Maghrouni A; Soltani A; Hashemy SI
Mol Biol Rep; 2021 May; 48(5):4797-4811. PubMed ID: 34057685
[TBL] [Abstract][Full Text] [Related]
17. Chaetocochin J, an epipolythiodioxopiperazine alkaloid, induces apoptosis and autophagy in colorectal cancer via AMPK and PI3K/AKT/mTOR pathways.
Hu S; Yin J; Yan S; Hu P; Huang J; Zhang G; Wang F; Tong Q; Zhang Y
Bioorg Chem; 2021 Apr; 109():104693. PubMed ID: 33609914
[TBL] [Abstract][Full Text] [Related]
18. FAT4 regulates the EMT and autophagy in colorectal cancer cells in part via the PI3K-AKT signaling axis.
Wei R; Xiao Y; Song Y; Yuan H; Luo J; Xu W
J Exp Clin Cancer Res; 2019 Mar; 38(1):112. PubMed ID: 30832706
[TBL] [Abstract][Full Text] [Related]
19. ESM1 promotes angiogenesis in colorectal cancer by activating PI3K/Akt/mTOR pathway, thus accelerating tumor progression.
Yang L; Dong Z; Li S; Chen T
Aging (Albany NY); 2023 Mar; 15(8):2920-2936. PubMed ID: 37100467
[TBL] [Abstract][Full Text] [Related]
20. To Investigate the Occurrence and Development of Colorectal Cancer Based on the PI3K/AKT/mTOR Signaling Pathway.
Zhong J; Ding S; Zhang X; Di W; Wang X; Zhang H; Chen Y; Zhang Y; Hu Y
Front Biosci (Landmark Ed); 2023 Feb; 28(2):37. PubMed ID: 36866550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]